Harvard Neuropsychiatry: A Comprehensive Update 2024
Harvard Neuropsychiatry: A Comprehensive Update 2024
Regular price
$70.00 USD
Regular price
$70.00 USD
Sale price
Unit price
/
per
Couldn't load pickup availability
Harvard Neuropsychiatry: A Comprehensive Update 2024
Regular price
$70.00
Regular price
$70.00
Sale price
Unit price
/
per
-
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author
2024 Course Overview
Harvard Neuropsychiatry: A Comprehensive Update 2024 Neuropsychiatry is an exciting and rapidly growing field that promotes an improved understanding of the brain/mind relationship. It seeks to elucidate the brain circuitry involved in primary psychiatric disorders such as mood, anxiety, psychotic, and somatic symptom disorders, and in neurological disorders that present with cognitive, emotional, or behavioral problems. The ultimate goal of neuropsychiatry is to advance diagnostic and treatment options for patients suffering from these disorders.
This course is designed to enhance participants’ knowledge of brain-behavior relationships and their skills for the diagnostic work-up and treatment of patients with neuropsychiatric disorders. Faculty will review cutting-edge clinical research, evidence-based interventions, and practical guidelines for the clinician. The course content will include the functional neuroanatomy of emotions, cognition, and behavior, the fundamentals of the neuropsychiatric exam and relevant ancillary tests, and neuropsychopharmacological and non-pharmacological interventions in neuropsychiatric disorders. We will discuss the neuropsychiatric aspects of traumatic brain injury, epilepsy, neurodegenerative disorders, neuroinflammatory disorder, multiple sclerosis, functional neurological disorders, sleep disorders, Tourette Syndrome and other neurodevelopmental disorders, addiction, pain, and other disorders. Learners will benefit from a variety of educational formats, including lectures, panel discussions, case discussions, question-and-answer sessions, and an electronic syllabus.
Who Should Attend
- Specialty Physicians
- Primary Care Physicians
- Psychologists
- Physician Assistants
- Nurses
- Nurse Practitioners
- Social Workers
- Pharmacists
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate brain-behavior relationships as they pertain to neuropsychiatric manifestations.
- Generate clinically meaningful differential diagnoses.
- Provide an inter-professional team-based approach to the assessment and treatment of neuropsychiatric disorders.
- Utilize up-to-date diagnostic criteria and assessment methods to evaluate and monitor patients with neuropsychiatric disorders.
- Implement evidence-based treatment recommendations and monitor patient response.
2024 Agenda
All agenda sessions are in Eastern Time.
Thursday, October 24, 2024
Day One
7:50-8:00 AM
Welcome & Introductory Remarks
8:00-8:40 AM
A Neuroanatomy Primer
Jeremy Schmahmann, MD
Jeremy Schmahmann, MD
8:40-9:20 AM
Functional Neurocircuitry of Affective and Behavioral Processes and Neuropsychiatric Syndromes
David Silbersweig, MD
David Silbersweig, MD
9:20-9:25 AM
Break
9:25-10:05 AM
Functional Neurocircuitry of Cognition and Cognitive Syndromes
Kirk Daffner, MD
Kirk Daffner, MD
10:05-10:25 AM
Panel Discussion and Q&A
10:25-10:40 AM
Break
10:40-11:20 AM
The Neuropsychiatric Exam and Ancillary Tests
Sheldon Benjamin, MD
Sheldon Benjamin, MD
11:20-11:50 AM
Neuroimaging in Clinical Neuropsychiatry
Joshua Klein, MD, PhD
Joshua Klein, MD, PhD
11:50 AM-12:20 PM
Neuropsychological Evaluation in Neuropsychiatry
Deborah Green, PhD, ABPP
Deborah Green, PhD, ABPP
12:20-12:40 PM
Panel Discussion and Q&A
12:40-1:30 PM
Break
1:30-2:00 PM
Brain Stimulation Therapies in Neuropsychiatry
Michael Fox, MD, PhD
Michael Fox, MD, PhD
2:00-2:50 PM
Psychopharmacology: Neuropsychiatric Syndromes
Jane Erb, MD
Jane Erb, MD
2:50-3:20 PM
Psychopharmacology: Drugs That Affect Cognition
Isaiah Kletenik, MD
Isaiah Kletenik, MD
3:20-3:40 PM
Panel Discussion and Q&A
3:40-3:50 PM
Break
3:50-4:40 PM
Psychosocial Interventions in Neuropsychiatry
Emma Weizenbaum, PhD; Abby Altman, PhD
Emma Weizenbaum, PhD; Abby Altman, PhD
4:40-5:10 PM
Forensic Neuropsychiatry
Jhilam Biswas, MD
Jhilam Biswas, MD
5:10-5:25 PM
Panel Discussion and Q&A
5:25-5:30 PM
Concluding Remarks
Friday, October 25, 2024
Day Two
7:50-8:00 AM
Welcome & Introductory Remarks for Day 2
8:00-8:40 AM
Acute and Subacute Neurocognitive Impairment
Scott McGinnis, MD
Scott McGinnis, MD
8:40-9:10 AM
Neuropsychiatry of Alzheimer’s Disease
Nancy Donovan, MD
Nancy Donovan, MD
9:10-9:40 AM
Neuropsychiatry of Parkinson’s Disease and Related Disorders
Stanley Lyndon, MD
Stanley Lyndon, MD
9:40-9:55 AM
Panel Discussion and Q&A
9:55-10:05 AM
Break
10:05-10:35 AM
Neuropsychiatric Aspects of Pain
Ginger Polich, MD
Ginger Polich, MD
10:35-11:25 AM
Neuropsychiatry of Inflammatory and Infectious Disorders
Jessica Harder, MD; Rishab Gupta, MBBS, MD
Jessica Harder, MD; Rishab Gupta, MBBS, MD
11:25-11:55 AM
Neuropsychiatric Aspects of Frontotemporal Dementia
Brad Dickerson, MD
Brad Dickerson, MD
11:55 AM-12:10 PM
Panel Discussion and Q&A
12:10-1:00 PM
Break
1:00-1:30 PM
Neuropsychiatry of Epilepsy
Daniel Weisholtz, MD
Daniel Weisholtz, MD
1:30-2:00 PM
Neuropsychiatry of Multiple Sclerosis
Laura T. Safar, MD
Laura T. Safar, MD
2:00-2:05 PM
Break
2:05-2:35 PM
Neuropsycho-oncology
Damien Miran, MD
Damien Miran, MD
2:35-3:15 PM
Neuropsychiatry of Traumatic Brain Injury
Thomas McAllister, MD
Thomas McAllister, MD
3:15- 3:30 PM
Panel Discussion and Q&A
3:30-3:40 PM
Break
3:40-4:10 PM
Pediatric Neuropsychiatry: Principles and Practice
Aaron Hauptman, MD
Aaron Hauptman, MD
4:10-4:40 PM
Psychopharmacology of Autism Spectrum Disorders
Christopher Keary, MD
Christopher Keary, MD
4:40-5:10 PM
Neuropsychiatry of Tourette Syndrome and Related Tic Disorders
Jeremiah Scharf, MD, PhD
Jeremiah Scharf, MD, PhD
5:10-5:25 PM
Panel Discussion and Q&A
5:25-5:30 PM
Concluding Remarks
Saturday, October 26, 2024
Day Three
7:50-8:00 AM
Welcome & Introductory Remarks for Day 3
8:00-8:30 AM
Optimizing Brain Health: Lifestyle, Aging and Disease Risk Reduction
Seth Gale, MD
Seth Gale, MD
8:30-9:00 AM
Neuropsychiatry of Sleep
Salma Batool-Anwar, MBBS, MPH
Salma Batool-Anwar, MBBS, MPH
9:00-9:30 AM
Neuropsychiatric Aspects of Addiction
Claudia Rodriguez, MD
Claudia Rodriguez, MD
9:30-9:45 AM
Panel Discussion and Q&A
9:45-9:55 AM
Break
9:55-10:25 AM
Functional Neurological Disorder
Gaston Baslet, MD
Gaston Baslet, MD
10:25-10:50 AM
Neuropsychiatric Aspects of Vascular and Metabolic Disorders
Juan Carlos Urizar, MD
Juan Carlos Urizar, MD
10:50-11:15 AM
Neuropsychiatric Aspects of Endocrine Disorders
Catherine Gonzalez, MD
Catherine Gonzalez, MD
11:15-11:45 PM
Holistic and Sustainable Management of Complex Neuropsychiatric Patients
Barry Fogel, MD
Barry Fogel, MD
11:45 AM-12:10 PM
Panel Discussion and Q&A
12:10-12:20 PM
Concluding Remarks
